Backing Down On Forward Funding? HHS Now Says It Won’t Make Multiple Year Awards Until September
In Brief: AACR Lectures Listed; Winn Heads Community Oncology At MDA; Henderson ACS Grant Renewed
FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin
B.J. Kennedy Receives ACCC Award, Says More Medical Oncologists Are Still Needed
Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”
McKenna Sees Budget Cuts as Threat to Year 2000 Goals Urges Stepped Up Efforts Against Tobacco Industry
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- CBER Director Vinay Prasad dared to “say no to drugs”
- Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC









